Developing Drugs Is an Expensive Process. How Do Biopharma Companies Hope to Change That?

Perhaps unsurprisingly, the average cost of developing new drugs is very high. For pharmaceutical companies that are developing multiple drugs, the R&D costs can average around $5 billion. This is concerning for pharma companies, especially considering that returns on R&D are the lowest they’ve been in the past nine years.